09/01/2026	08/25/2026	Fresenius Medical Care AG & Co. KGaA	Center for Drug Evaluation and Research (CDER)	CGMP/Finished Pharmaceuticals/Adulterated
09/01/2026	08/18/2026	PReye, LLC	Center for Drug Evaluation and Research (CDER)	CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug
09/01/2026	08/24/2026	Peak Performance Peptides	Center for Drug Evaluation and Research (CDER)	Unapproved New Drugs/Misbranded
09/01/2026	08/18/2026	B&P Mutual Corp	Office of Inspections and Investigations	Foreign Supplier Verification Program (FSVP)
08/25/2026	07/27/2026	Vargas Produce LLC	Office of Inspections and Investigations	Foreign Supplier Verification Program (FSVP)
08/25/2026	08/14/2026	R3 Medical Companies	Center for Biologics Evaluation and Research (CBER)	Unapproved New Drugs/Unlicensed Biological Product Violations
08/18/2026	08/06/2026	Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd.	Center for Drug Evaluation and Research (CDER)	CGMP/Active Pharmaceutical Ingredient (API)/Adulterated/Misbranded
08/18/2026	07/24/2026	Nipro Renal Solutions USA, Corporation	Center for Devices and Radiological Health	CGMP/QSR/Medical Devices/Adulterated
08/18/2026	08/12/2026	K.C. Pharmaceuticals, Inc.	Center for Drug Evaluation and Research (CDER)	CGMP/Finished Pharmaceuticals/Adulterated
08/18/2026	08/13/2026	Suretec Innovations, LLC	Center for Drug Evaluation and Research (CDER)	CGMP/Finished Pharmaceuticals/Adulterated and Misbranded

Showing 11 to 20 of 3,679 entries

• First
• Previous
• 1
• 2
  
  

 

09/08/2026	09/01/2026	Happy Farm Botanicals, Inc.	Center for Drug Evaluation and Research (CDER)	CGMP/Finished Pharmaceuticals/Adulterated
09/08/2026	08/27/2026	Stephen J. Fallon, Ph.D.	Center for Biologics Evaluation and Research (CBER)	Bioresearch Monitoring Program/Institutional Review Board (IRB)
09/01/2026	08/24/2026	Peak Performance Peptides	Center for Drug Evaluation and Research (CDER)	Unapproved New Drugs/Misbranded
09/01/2026	08/18/2026	Reliance Life Sciences Private Limited	Center for Drug Evaluation and Research (CDER)	CGMP/Finished Pharmaceuticals/Adulterated
09/01/2026	08/27/2026	Jabil Inc.	Center for Drug Evaluation and Research (CDER)	CGMP/Finished Pharmaceuticals/Adulterated
09/01/2026	08/18/2026	Shoolin Pharma Chem LLP	Center for Drug Evaluation and Research (CDER)	CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
09/01/2026	08/24/2026	Royal Peptides LLC	Center for Drug Evaluation and Research (CDER)	Unapproved New Drugs/Misbranded
09/01/2026	08/24/2026	NuScience Peptides LLC	Center for Drug Evaluation and Research (CDER)	Unapproved New Drugs/Misbranded
09/01/2026	08/24/2026	Peptide Partners LLC	Center for Drug Evaluation and Research (CDER)	Unapproved New Drugs/Misbranded
09/01/2026	08/24/2026	TXP Innovations LLC dba Tex Peptides	Center for Drug Evaluation and Research (CDER)	Unapproved New Drugs/Misbranded

Kratom Leaf

 Williamston police speak with businesses on banned substance

FDA screens GLP-! Ingredients at the Border and Warns of Vials Labeled with Pharmacies That Do Not Exist Published Sep 02, 2026 3:30 PM EDT By Dorothy Brooks

 

Medical Daily

https://www.medicaldaily.com › fda-glp1-import-alert-c...

1 day ago — DA has an import alert on GLP-1 ingredients with quality concerns and warns of fraudulent compounded semaglutide carrying false pharmacy names.

The Compounding Loophole Has Become a Business Model By Peter Pitts August 31, 2026

 

RealClearHealth

https://www.realclearhealth.com › articles › 2026/08/31

3 days ago — A pharmacist preparing an individualized medicine for a patient who cannot use an FDA-approved formulation is practicing compounding as it was intended. And ...Read more

AARP: Compounded Medications What Older Adults Should Know

 

AARP

https://www.aarp.org › health › drugs-supplements › co...

7 days ago — Compounded medications are custom-made drugs prepared by specialized pharmacies for patients whose needs can't be met by a standard, commercially available ...Read more

FDA Issues Draft Guidance on Compounding Animal Drugs from Bulk Drug Substances Under Current Good Manufacturing Practice in Federally-Registered Facilities

 FDA Issues Draft Guidance on Compounding Animal Drugs from Bulk Drug Substances Under Current Good Manufacturing Practice in Federally-Registered Facilities | FDA

FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss

 

..

U.S. Food and Drug Administration (.gov)

https://www.fda.gov › drugs › drug-alerts-and-statements

3 days ago — A compounded drug might be appropriate if a patient's medical need cannot be met by an FDA-approved drug, or the FDA-approved drug is not commercially available ...Read more

Column: Drug compounding has changed. Oversight should too

 Column: Drug compounding has changed. Oversight should too – The Virginian-Pilot

Surge in unapproved, compounded GLP-1 drugs. Are they safe? The CA Poison Control System says it's receiving constant calls from people reporting getting sick and even hospitalized after taking GLP-1 drugs, many of them unapproved compounds.

 

NBC Bay Area

https://www.nbcbayarea.com › news › local › unapprov...

2 days ago — Compounded GLP-1 medications are mixed versions of the popular name brand weight loss drugs like Ozempic. They were initially created to address a drug shortage